Polar Asset Management Partners Inc. Immunome Inc. Transaction History
Polar Asset Management Partners Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Polar Asset Management Partners Inc. transactions in Immunome Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 21,800 shares of IMNM stock, worth $234,568. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,800
Previous 21,800
-0.0%
Holding current value
$234,568
Previous $263,000
20.91%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding IMNM
# of Institutions
121Shares Held
47.1MCall Options Held
304KPut Options Held
1.91M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.76MShares$62 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.89MShares$52.6 Million4.67% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$41.7 Million2.46% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$40.4 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.49MShares$37.5 Million0.03% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $130M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...